期刊文献+

恶性黑素瘤的最新动态(七) 被引量:1

下载PDF
导出
摘要 1少见的恶性黑素瘤 1.1葡萄膜MM:葡萄膜MM很少见,每年每一百万人群中可新发现5~7个患者。白色人种发生几率多于黑色人种,除家族史有眼部黑素细胞增多者与发病有关外、其他与发病相关的因素还不甚了解。除葡萄膜MM外,眼部的色素细胞还可引发虹膜异色性、脉络膜异色性和青光眼。葡萄膜删有虹膜、睫状体、脉络膜三个类型。
作者 李荟元
出处 《中国美容医学》 CAS 2008年第7期1085-1087,共3页 Chinese Journal of Aesthetic Medicine
  • 相关文献

参考文献12

  • 1Singh AD,Kalyani P,Topham A.Estimating the risk of malignant transformation of a choroidal nevus [J].Ophthalmology,2005,112: 1784-1789.
  • 2Singh AD,Bergman L,Seregard S.Uveal melanoma:epidemiologic aspects[J]. Ophthalmot Clin North Am,2005,18:75 -84.
  • 3Singh AD,Borden ECMetastatic uveal melanoma [J].Ophthalmol Clin North Am,2005,18:143 - 150.
  • 4Singh AD,Kivela T.The collaborative ocular melanoma study [J]. Ophthalmol Clin North Am,2005,18:129-142.
  • 5Nordlund JR,Robertson DM,Herman DC.Ultrasound biomicroscopy in management of malignant iris melanoma[J]. Arch Ophthalmol,2003,121:725-727.
  • 6Conway RM, Chua WC,Qureshi C,et al. Primary iris melanoma: diagnostic features and outcome of conservative surgical treatment[J].Br J Ophthalmol,2001,85:848-854.
  • 7Autier P,Dore JF,Reis AC,et al.Sunscreen use and intentional exposure to ultraviolet A and B radiation: a double blind randomized trial using personal dosimeters[J].Br J Cancer,2000,83:1243-1248.
  • 8Umeda M, Komatsubara H, Shibuya Y,et al. Premalignant melanocytic dysplasia and malignant melanoma of the oral mucosa [J].Oral Oncol, 2002,38:714-722.
  • 9Ross MI,Cormier JN,Xing Y,et al. Prognosis and survival outcomes in melanoma patients with unknown primary site (MUP)[J].J Clin Oncol, 2004,22(suppl):721 s.
  • 10Anbari KK, Schuchter LM,Bucky LP,et al.University of Pennsylvania Pigmented Lesion Study Group. Melanoma of unknown primary site: presentation, treatment, and prognosis: a single institution study [J]. Cancer,1997,79:1816-1821.

同被引文献13

  • 1姜会庆,胡心宝,汪涌,汪军,解伟光,陈一飞.头部恶性黑色素瘤扩大切除及自体皮移植[J].医学研究生学报,2004,17(11):1049-1049. 被引量:1
  • 2张诗武,孙保存,赵秀兰,刘岩雪,郝希山.恶性黑色素瘤浸润转移相关分子机制研究[J].天津医药,2005,33(2):65-67. 被引量:3
  • 3李蠡,薛春雨,邢新.恶性黑色素瘤细胞凋亡特点的研究进展[J].医学研究生学报,2005,18(9):849-852. 被引量:5
  • 4雷静,韩丹,王克超.恶性黑色素瘤的CT诊断[J].临床放射学杂志,2006,25(8):727-730. 被引量:13
  • 5Seely S. Possible reasons for the high resistance of muscle to cancer[J]. Med Hypotheses, 1980,6:133-137.
  • 6Laggner U,Perera G,Lopez JS, et al. Regression of melanoma metastases following treatment with the n-bisphosphonate zoledronate and localised radiotherapy[J]. Clin Immunol, 2009,131(3): 367-373.
  • 7Green JR, Clezardin P. Mechanisms of bisphosphonate effects on osteoclasts, tumor cell growth, and metastasis[J]. Am J Clin Oncol,2002,25(6):S3-9.
  • 8Hayday AC. γΔ cells: a right time and a right place for a conserved third way of protection[J]. Annu Rev Immunol, 2000,18:975-1026.
  • 9Kabelitz D, Wesch D, He W. Perspectives of gammadelta T cells in tumor immunology[J]. Cancer Res, 2007,67(1):5-8.
  • 10Kabelitz D, Wesch D, Pitters E, et al. Characterization of tumor reactivity of human V gamma 9V delta 2 gamma delta T cells in vitro and in SCID mice in vivo[J]. J Immunol, 2004,173(11):6767-6776.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部